Interferon-α plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: A pilot study Robert J. AmatoAnish Rawat Preclinical Studies 02 August 2005 Pages: 171 - 175
Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme Daniel FarrayManmeet S. AhluwaliaDavid M. Peereboom Preclinical Studies 02 August 2005 Pages: 177 - 180
Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product Wei ZhangEdgar S. L. LiuShiu-Fun Pang Preclinical Studies 02 August 2005 Pages: 181 - 187
Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial Sanjay Singh NegiAnil AgarwalAdarsh Chaudhary Preclinical Studies 17 August 2005 Pages: 189 - 194
Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures José M. PadrónGodefridus J. Peters Preclinical Studies 20 September 2005 Pages: 195 - 202
Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer Athanassios ArgirisVictoria KutMichael J. Avram Phase I Studies 02 August 2005 Pages: 203 - 212
A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer Patrapim SunpaweravongLyn MagreeKaren Kelly Phase I Studies 20 September 2005 Pages: 213 - 221
Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks Peter JohnsonThomas GeldartIan Judson Phase I Studies 20 September 2005 Pages: 223 - 231
Phase I trial of oral talactoferrin alfa in refractory solid tumors Teresa G. HayesGerald F. FalchookAtul Varadhachary Phase I Studies 20 September 2005 Pages: 233 - 240
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study Emilio EstebanJoaquin Fraon behalf of the Grupo Oncológico del Norte de España (“GON”) Phase II Studies 02 August 2005 Pages: 241 - 248
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma J. T. HartmannK. OechsleC. Bokemeyer Phase II Studies 17 August 2005 Pages: 249 - 253
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma Michael HuieKurt OettelGeorge Wilding Phase II Studies 20 September 2005 Pages: 255 - 260